Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 26-Feb-24 4:11 PM View:  | Equifax Inc. (EFX) | 23-Feb-24 | Payment of Exercise | 44,834 | $265.18 | $11,889,100.00 | (41%) 110.64K to 65.81K | |
| 26-Feb-24 4:11 PM View: | Equifax Inc. (EFX) | 23-Feb-24 | Option Exercise | 60,546 | $139.83 | $8,466,330.00 | 121% 50.1K to 110.64K | |
| 14-Feb-24 4:49 PM View: | Equifax Inc. (EFX) | 12-Feb-24 | Grant | 5,750 | -- | -- | 12% 48.08K to 53.83K | |
| 14-Feb-24 4:49 PM View: | Equifax Inc. (EFX) | 12-Feb-24 | Payment of Exercise | 3,732 | $255.78 | $954,571.00 | (7%) 53.83K to 50.1K | |
| 13-Feb-24 4:10 PM View: | Equifax Inc. (EFX) | 09-Feb-24 | Grant | 4,014 | -- | -- | 9% 44.07K to 48.08K | |
| 04-Aug-23 4:09 PM View: | Equifax Inc. (EFX) | 02-Aug-23 | Sale (Planned) | 2,500 | $201.33 | $503,319.00 | (5%) 46.53K to 44.03K | |
| 30-May-23 4:15 PM View: | Equifax Inc. (EFX) | 25-May-23 | Sale (Planned) | 6,500 | $207.03 | $1,345,680.00 | (12%) 53.01K to 46.51K | |
| 23-Feb-23 4:07 PM View: | Equifax Inc. (EFX) | 21-Feb-23 | Grant | 5,706 | -- | -- | 11% 50.94K to 56.65K | |
| 23-Feb-23 4:07 PM View: | Equifax Inc. (EFX) | 21-Feb-23 | Payment of Exercise | 3,661 | $203.81 | $746,148.00 | (6%) 56.65K to 52.99K | |
| 14-Feb-23 10:00 PM View: | Equifax Inc. (EFX) | 10-Feb-23 | Grant | 4,851 | -- | -- | 11% 46.09K to 50.94K | |
| 28-Oct-22 4:12 PM View: | Equifax Inc. (EFX) | 26-Oct-22 | Sale (Planned) | 15,000 | $165.52 | $2,482,850.00 | (25%) 61.07K to 46.07K | |
| 25-Mar-22 4:29 PM View: | Cyrusone Inc. (CONE) | 25-Mar-22 | Disposition | 26,353 | -- | -- | (100%) 26.35K to 0 | |
| 24-Feb-22 4:11 PM View: | Equifax Inc. (EFX) | 22-Feb-22 | Grant | 21,974 | -- | -- | 44% 50.37K to 72.35K | |
| 24-Feb-22 4:11 PM View: | Equifax Inc. (EFX) | 22-Feb-22 | Payment of Exercise | 11,324 | $212.24 | $2,403,410.00 | (16%) 72.35K to 61.02K | |
| 15-Feb-22 5:33 PM View: | Equifax Inc. (EFX) | 11-Feb-22 | Grant | 3,612 | -- | -- | 8% 46.76K to 50.37K | |
| 29-Jul-21 4:18 PM View: | Equifax Inc. (EFX) | 27-Jul-21 | Payment of Exercise | 1,887 | $258.29 | $487,393.00 | (4%) 48.63K to 46.74K | (< 1%) |
| 20-May-21 6:29 PM View: | Cyrusone Inc. (CONE) | 18-May-21 | Grant | 2,037 | -- | -- | 9% 23.85K to 25.88K | |
| 09-Mar-21 4:20 PM View: | Equifax Inc. (EFX) | 05-Mar-21 | Grant | 9,447 | -- | -- | 21% 44.69K to 54.13K | |
| 09-Mar-21 4:20 PM View: | Equifax Inc. (EFX) | 05-Mar-21 | Payment of Exercise | 5,561 | $169.75 | $943,980.00 | (10%) 54.13K to 48.57K | (39%) |
| 17-Feb-21 5:22 PM View: | Equifax Inc. (EFX) | 12-Feb-21 | Grant | 2,469 | -- | -- | 6% 42.22K to 44.69K | |
| 31-Jul-20 4:08 PM View: | Equifax Inc. (EFX) | 29-Jul-20 | Market Sale (Planned) | 17,500 | $164.77 | $2,883,470.00 | (29%) 59.66K to 42.16K | (43%) |
| 04-May-20 5:02 PM View: | Cyrusone Inc. (CONE) | 30-Apr-20 | Grant | 2,139 | -- | -- | 10% 21.13K to 23.26K | |
| 25-Feb-20 4:56 PM View: | Equifax Inc. (EFX) | 21-Feb-20 | Grant | 2,351 | -- | -- | 4% 57.25K to 59.6K | |
| 21-Feb-20 4:11 PM View: | Equifax Inc. (EFX) | 19-Feb-20 | Grant | 1,573 | -- | -- | 3% 56.39K to 57.96K | |
| 21-Feb-20 4:11 PM View: | Equifax Inc. (EFX) | 19-Feb-20 | Payment of Exercise | 710 | $161.88 | $114,935.00 | (1%) 57.96K to 57.25K | (45%) |
| 19-Feb-20 5:02 PM View: | Equifax Inc. (EFX) | 16-Feb-20 | Payment of Exercise | 1,217 | $159.63 | $194,270.00 | (2%) 57.6K to 56.39K | (47%) |
| 26-Feb-19 10:00 PM View: | Equifax Inc. (EFX) | 22-Feb-19 | Grant | 3,047 | -- | -- | 6% 54.41K to 57.46K | |
| 25-Feb-19 5:06 PM View: | Cyrusone Inc. (CONE) | 21-Feb-19 | Grant | 2,383 | -- | -- | 13% 18.04K to 20.43K | |
| 20-Feb-19 4:50 PM View: | Equifax Inc. (EFX) | 18-Feb-19 | Grant | 2,362 | -- | -- | 4% 55.05K to 57.41K | |
| 20-Feb-19 4:50 PM View: | Equifax Inc. (EFX) | 18-Feb-19 | Payment of Exercise | 3,004 | $109.32 | $328,397.00 | (5%) 57.41K to 54.41K | (114%) |
| 31-Jul-18 4:52 PM View: | Equifax Inc. (EFX) | 27-Jul-18 | Grant | 4,049 | -- | -- | 4% 105.92K to 109.97K | |
| 07-Mar-18 5:20 PM View: | Equifax Inc. (EFX) | 05-Mar-18 | Grant | 2,781 | -- | -- | 6% 48.12K to 50.9K | |
| 28-Feb-18 6:11 PM View: | Cyrusone Inc. (CONE) | 26-Feb-18 | Grant | 2,436 | -- | -- | 16% 15.09K to 17.53K | |
| 21-Feb-18 5:35 PM View: | Equifax Inc. (EFX) | 19-Feb-18 | Grant | 14,560 | -- | -- | 35% 42.11K to 56.67K | |
| 21-Feb-18 5:35 PM View: | Equifax Inc. (EFX) | 19-Feb-18 | Payment of Exercise | 8,550 | $117.46 | $1,004,280.00 | (15%) 56.67K to 48.12K | (97%) |
| 03-Aug-17 4:21 PM View: | Equifax Inc. (EFX) | 01-Aug-17 | Market Sale | 6,500 | $145.60 | $946,374.00 | (13%) 48.58K to 42.08K | (58%) |
| 24-May-17 4:15 PM View: | Equifax Inc. (EFX) | 23-May-17 | Market Sale | 14,000 | $136.44 | $1,910,130.00 | (22%) 62.58K to 48.58K | (68%) |
| 22-May-17 4:04 PM View: | Equifax Inc. (EFX) | 21-May-17 | Grant | 18,736 | -- | -- | 21% 91.18K to 109.92K | |
| 22-May-17 4:04 PM View: | Equifax Inc. (EFX) | 21-May-17 | Payment of Exercise | 47,337 | $136.37 | $6,455,350.00 | (43%) 109.92K to 62.58K | (68%) |
| 21-Feb-17 6:01 AM View: | Equifax Inc. (EFX) | 16-Feb-17 | Grant | 2,598 | -- | -- | 3% 88.58K to 91.18K | |
| 15-Feb-17 6:57 PM View: | Cyrusone Inc. (CONE) | 13-Feb-17 | Grant | 2,597 | -- | -- | 21% 12.23K to 14.83K | |
| 22-Feb-16 4:20 PM View: | Equifax Inc. (EFX) | 18-Feb-16 | Grant | 4,295 | -- | -- | 5% 84.29K to 88.58K | |
| 03-Feb-16 5:13 PM View: | Cyrusone Inc. (CONE) | 01-Feb-16 | Grant | 2,974 | -- | -- | 32% 9.26K to 12.23K | |
| 20-Feb-15 2:33 PM View: | Equifax Inc. (EFX) | 19-Feb-15 | Grant | 4,302 | -- | -- | 5% 79.98K to 84.29K | |
| 12-Feb-15 4:30 PM View: | Cyrusone Inc. (CONE) | 10-Feb-15 | Grant | 3,871 | $28.42 | $110,014.00 | 72% 5.39K to 9.26K | 139% |
| 04-Aug-14 3:22 PM View: | Cyrusone Inc. (CONE) | 01-Aug-14 | Grant | 405 | $24.72 | $10,011.60 | 8% 4.99K to 5.39K | 174% |
| 22-May-14 3:49 PM View: | Equifax Inc. (EFX) | 21-May-14 | Grant | 79,984 | -- | -- | 100% 0 to 79.98K | |
| 21-May-14 4:20 PM View: | Lexmark International Inc. (LXK) | 20-May-14 | Option Exercise | 8,000 | $33.26 | $266,080.00 | 7% 122.77K to 130.77K | |
| 21-May-14 4:20 PM View: | Lexmark International Inc. (LXK) | 20-May-14 | Market Option Sale | 8,000 | $42.53 | $340,246.00 | (6%) 130.77K to 122.77K | (6%) |
| 20-May-14 4:33 PM View: | Lexmark International Inc. (LXK) | 19-May-14 | Option Exercise | 16,000 | $17.12 | $273,920.00 | 13% 122.77K to 138.77K |